Post-marketing Surveillance Study of GSK Biologicals' Pneumococcal Conjugate Vaccine, Synflorix, When Administered According to the Local Prescribing Information in Philippines.
Phase of Trial: Phase IV
Latest Information Update: 27 May 2016
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary)
- Indications Otitis media; Pneumococcal infections; Pneumonia
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 08 Jun 2014 According to ClinicalTrials.gov record, status changed from recruiting to discontinued.
- 23 Mar 2012 Planned end date changed from 1 Jun 2013 to 1 Apr 2015 as reported by ClinicalTrials.gov.
- 31 Jan 2011 Planned end date changed from 1 Sep 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.